Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change
- 1 February 1994
- journal article
- research article
- Published by Springer Nature in Archiv Fur Psychiatrie Und Nervenkrankheiten
- Vol. 243 (5) , 291-292
- https://doi.org/10.1007/bf02191587
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Apolipoprotein E and Alzheimer's diseaseThe Lancet, 1993
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Psychotic features and the course of Alzheimer's disease: relationship to cognitive, electroencephalographic and computerized tomography findingsActa Psychiatrica Scandinavica, 1993
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences, 1993
- Alzheimer's disease: clinical FeaturesInternational Review of Psychiatry, 1993
- Apolipoprotein E genotyping by one-stage PCRThe Lancet, 1991
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984